webinar register page

Webinar banner
Implementation of HIV Management Guidelines: TLD vs TEE
The 2020 South African HIV Management Guidelines recommend the use of the dolutegravir-based regimens as the preferred first-line and second-line treatment for all populations, including pregnant women and those of childbearing potential.

This webinar aims to clarify any conflicting information, share evidence that will improve the confidence of healthcare providers to initiate ARV regimens as per national clinical guidelines, improve communication and client counselling.

Jun 8, 2022 02:00 PM in Johannesburg

Webinar is over, you cannot register now. If you have any questions, please contact Webinar host: .